|
|
|
|
|
|
| |
Since 1937, the Annual Report on the Results of Treatment in Gynecological Cancer
has provided the greatest comparability between therapeutic statistics in cancers
of the female tract with the aim of securing reliable evaluation of the different
therapeutic treatments and methods.
The unique feature of the FIGO Annual Report Project is the collection of data
from many different institutions all over the world, where we know from
epidemiology that cancer incidence, prevalence, treatments and survivals may be
strikingly different.
The FIGO Annual Report remains a truly ongoing piece of gynaecological history
and tradition.
It also represents an unmatched publication in the gynaecological literature.
The various volumes of the Annual Report provide the gynaecologist/gynaecologic
oncologist a glimpse into the treatment modalities used by different institutions
world-wide and their respective results.
Since 1973, the Annual Report has been published every three years to coincide
with the year of the FIGO World Congress
In more recent years, the data contained in the volumes of the Annual Report have
helped developing treatment guidelines for female cancers and provided clinicians
with valuable prognostic information.
Every three years, since the year 2000, the FIGO Committee on Gynecologic Oncology
has published a booklet on the Staging Classifications and Clinical Practice
Guidelines for Gynaecological Cancers in collaboration with the
Guidelines Committee of the International Gynecologic Cancer Society (IGCS)
Download the 2006 FIGO/IGCS edition of the guidelines
More on the history of the Annual Report
Join the project now
|
|
|
|
Contributing to the Annual Report |
|
| |
The first three volumes of the Annual Report were published in 1937, 1938 and
1939, and contained only the results of cervical cancer patients treated with
radiotherapy, but indicated that future volumes would be expanded to include
material relating to endometrial and vaginal cancer.
The contributing centres of Volume 1 were the Centre of Tumors from the
University of Brussels (Brussels, Belgium), Liverpool Radium Institute
(Liverpool, UK), Marie Curie Hospital (London, UK),the Radium Centre for
Carcinoma of the Uterus – the London County Council (London, UK), the Institute
for Radium – University of Paris (Paris, France), and the Radiumhemmet
(Stockholm, Sweden) where the Editorial Office was established in 1937.
The Editorial Office remained in Stockholm under the guidance of three Editors:
J Heyman (1937-1956), Dr. HL Kottmeier (1956-1982), and
Dr. F Pettersson (1982-1994).
In 1994, with the impending retirement of Dr. Pettersson, the FIGO Executive
Board approved moving the Office to the European Institute of Oncology in
Milan (Italy) with Sergio Pecorelli as the new Editor.
From the initial six collaborators, the number of contributing centres has
grown over the years.
At the time of publication of the Twenty-sixth Volume in 2006, 108 international
cancer institutes and gynaecological clinics have submitted data on their patients.
In order to provide gynaecologists/gynaecologic oncologists with more thorough
statistics and data analysis on gynaecological malignancies, the Editorial Board
welcome any new institution wishing to contribute to our project.
Join the project now
|
|
|
|
